Published in Cancer Weekly, March 9th, 2004
Scientists found the technique - known as nuclear magnetic resonance (NMR) - was able to predict at an early stage how a brain tumor called a glioma was responding to treatment with the drug temozolomide.
The team of researchers, funded by Cancer Research U.K. and the Medical Research Council, at the Institute of Cancer Research, developed the scan from a machine widely used to identify molecules in chemistry laboratories. Their findings were published in the British Journal of Cancer.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.